Posts in tag

pain management


Debbie Rigby rounds up the latest in research news  Overdiagnosis of Penicillin Allergy Leads to Costly, Inappropriate Treatment A growing body of evidence suggests that as few as 10% of …

A new paper from the SHPA has exposed national inconsistencies in provision of pharmacy services to reduce the risk of opioid misuse “These tablets, they’re not lollies,” outgoing president of …

by Shalini Arunogiri, Monash University; Dan Lubman, Monash University, and Rose Crossin, Monash University Pregabalin (sold under the brand name Lyrica) is prescribed as an anti-epileptic and a painkiller for …

As Victorians head to the polls, we wrap up the last week in community pharmacy The Pharmacy Guild‘s Anthony Tassone has supported one measure announced by Victoria’s Liberal National Opposition—an …

The Victorian Opposition has pledged to both invest in pain services, and shut down Richmond’s injecting room Anthony Tassone, president of the Pharmacy Guild’s Victorian branch, has welcomed the former …

New PBS data shows that opioid prevalence in Australia has increased since 2013, but incidence has decreased And in response, pain stakeholders have called for better access to multi-disciplinary treatments, …

The Pharmacy Guild of Australia has announced services have started under the Chronic Pain MedsCheck Trial Participating community pharmacies that have completed the required training will start recording trial services …

More hospitalisations are caused by side effects of intended use of licit opioids, than from illicit use or misuse Harms highlighted in a new report underline the pressing need for …

Pain groups have questioned the upcoming implementation of the national real time prescription monitoring system, saying it puts the “cart before the horse” But the Pharmacy Guild’s Anthony Tassone has …

The Guild defends its Chronic Pain MedsCheck Trial after further criticism, this time from a leading Australian pain specialist body The Faculty of Pain Medicine of the Australian and New …

AFT Pharmaceuticals has engaged in false and misleading conduct in its Maxigesic advertising, the Federal Court has found The Court found that AFT, the manufacturer of the pain relief brand …

Pharmacists are warned they may see more pain sufferers heading back to prescription opioids and excluded from private care The Neuromodulation Society of Australia and New Zealand has expressed concerns …